222 related articles for article (PubMed ID: 18543757)
1. [Mechanism of therapy effects by botulinum neurotoxin].
Alajbegović A; Alajbegović S; Resić H
Med Arh; 2008; 62(1):53-5. PubMed ID: 18543757
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of botulinum toxin in neurological indications.
Ward AB; Molenaers G; Colosimo C; Berardelli A
Eur J Neurol; 2006 Dec; 13 Suppl 4():20-6. PubMed ID: 17112346
[TBL] [Abstract][Full Text] [Related]
3. [Use of botulinum neurotoxin therapy].
Mukai Y; Kaji R
Brain Nerve; 2011 Jul; 63(7):775-84. PubMed ID: 21747148
[TBL] [Abstract][Full Text] [Related]
4. [Indications and management of botulinum toxin].
Singer C
Rev Neurol; 1999 Jul 16-31; 29(2):157-62. PubMed ID: 10528331
[TBL] [Abstract][Full Text] [Related]
5. More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system.
Mazzocchio R; Caleo M
Neuroscientist; 2015 Feb; 21(1):44-61. PubMed ID: 24576870
[TBL] [Abstract][Full Text] [Related]
6. Use of botulinum toxin A in adult neurological disorders: efficacy, tolerability and safety.
Schulte-Mattler WJ
CNS Drugs; 2008; 22(9):725-38. PubMed ID: 18698873
[TBL] [Abstract][Full Text] [Related]
7. Clinical differences between botulinum neurotoxin type A and B.
Bentivoglio AR; Del Grande A; Petracca M; Ialongo T; Ricciardi L
Toxicon; 2015 Dec; 107(Pt A):77-84. PubMed ID: 26260691
[TBL] [Abstract][Full Text] [Related]
8. Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders.
Luvisetto S; Gazerani P; Cianchetti C; Pavone F
Toxins (Basel); 2015 Sep; 7(9):3818-44. PubMed ID: 26404377
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.
Hallett M; Albanese A; Dressler D; Segal KR; Simpson DM; Truong D; Jankovic J
Toxicon; 2013 Jun; 67():94-114. PubMed ID: 23380701
[TBL] [Abstract][Full Text] [Related]
10. Botulinum neurotoxin for the treatment of movement disorders.
Kopanidis P; Das C
Aust J Gen Pract; 2018 Sep; 47(9):598-601. PubMed ID: 30244558
[TBL] [Abstract][Full Text] [Related]
11. Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators.
Dolly JO; Wang J; Zurawski TH; Meng J
FEBS J; 2011 Dec; 278(23):4454-66. PubMed ID: 21645262
[TBL] [Abstract][Full Text] [Related]
12. An Update on Botulinum Toxin in Neurology.
Chiu SY; Burns MR; Malaty IA
Neurol Clin; 2021 Feb; 39(1):209-229. PubMed ID: 33223084
[TBL] [Abstract][Full Text] [Related]
13. Botulinum neurotoxin A for chronic migraine headaches: does it work and how?
Cairns BE; Gazerani P
Pain Manag; 2014; 4(6):377-80. PubMed ID: 25494688
[No Abstract] [Full Text] [Related]
14. The structure and mode of action of different botulinum toxins.
Dolly JO; Aoki KR
Eur J Neurol; 2006 Dec; 13 Suppl 4():1-9. PubMed ID: 17112344
[TBL] [Abstract][Full Text] [Related]
15. [Applications of botulinum toxin in Neurology].
Garcia-Ruiz PJ
Med Clin (Barc); 2013 Jul; 141(1):33-6. PubMed ID: 23434466
[TBL] [Abstract][Full Text] [Related]
16. Unlabeled uses of botulinum toxins: a review, part 2.
Cheng CM; Chen JS; Patel RP
Am J Health Syst Pharm; 2006 Feb; 63(3):225-32. PubMed ID: 16434781
[TBL] [Abstract][Full Text] [Related]
17. Chapter 3: Molecular basis for the therapeutic effectiveness of botulinum neurotoxin type A.
Dolly JO; Lawrence GW
Neurourol Urodyn; 2014 Jul; 33 Suppl 3():S14-20. PubMed ID: 25042137
[TBL] [Abstract][Full Text] [Related]
18. The evolution of botulinum neurotoxin type A for cosmetic applications.
Carruthers J; Carruthers A
J Cosmet Laser Ther; 2007 Sep; 9(3):186-92. PubMed ID: 17763029
[TBL] [Abstract][Full Text] [Related]
19. Reduction of TRPV1 expression in the trigeminal system by botulinum neurotoxin type-A.
Shimizu T; Shibata M; Toriumi H; Iwashita T; Funakubo M; Sato H; Kuroi T; Ebine T; Koizumi K; Suzuki N
Neurobiol Dis; 2012 Dec; 48(3):367-78. PubMed ID: 22820141
[TBL] [Abstract][Full Text] [Related]
20. Botulinum neurotoxin serotypes A and C do not affect motor units survival in humans: an electrophysiological study by motor units counting.
Eleopra R; Tugnoli V; Quatrale R; Gastaldo E; Rossetto O; De Grandis D; Montecucco C
Clin Neurophysiol; 2002 Aug; 113(8):1258-64. PubMed ID: 12140005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
